Vir Biotechnology, Inc. Contracts & Agreements

100 Contracts & Agreements
Browse by Contract Category
Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Sub-License and Collaboration Agreement between the Registrant (as successor in interest to Humabs BioMed SA) and MedImmune, LLC, dated March 20, 2012
Collaboration Agreements
Vir Biotechnology, Inc.
Biotechnology
NY
2019
Amendment No.3 to the Other Transaction for Advanced Research (OTAR) between the Company and the United States of America Department of Health and Human Services, Administration...
Development Agreements
Vir Biotechnology, Inc.
2024
Amendment No. 2 to the Other Transaction for Advanced Research (OTAR) between the Company and the United States of America Department of Health and Human Services, Administration...
Development Agreements
Vir Biotechnology, Inc.
2024
Offer Letter between the Company and Jason O'Byrne, dated September 6, 2024
Vir Biotechnology, Inc.
2024
License Agreement between
License Agreements
Vir Biotechnology, Inc.
2024
Letter Agreement between the Company and Glaxo Wellcome UK Limited, dated February 21, 2024
Vir Biotechnology, Inc.
2024
Amendment No. 1 to the Other Transaction for Advanced Research (OTAR) between the Company and the United States of America Department of Health and Human Services, Administration...
Development Agreements
Vir Biotechnology, Inc.
2023
Other Transaction for Advanced Research (OTAR) between the Company and the United States of America Department of Health and Human Services, Administration for Strategic...
Development Agreements
Vir Biotechnology, Inc.
2023
Separation Agreement between Vir Biotechnology International GmbH and Johanna Friedl-Naderer, dated September 23, 2023
Separation Agreements
Vir Biotechnology, Inc.
2023
Amendment No. 1 to the Definitive Collaboration Agreement between the Company and Glaxo Wellcome UK Limited dated May 27, 2022
Collaboration Agreements
Vir Biotechnology, Inc.
Biotechnology
DE
2022
Termination Agreement between the Company and WuXi Biologics (Hong Kong) Limited dated May 16, 2022
Termination Agreements
Vir Biotechnology, Inc.
Biotechnology
CA
2022
Stock Purchase Agreement between the Company and the Bill & Melinda Gates Foundation, dated January 12, 2022
Stock Agreements
Vir Biotechnology, Inc.
2022
Amendment No. 5 to Grant Agreement between the Company and the Bill & Melinda Gates Foundation, dated December 8, 2021
Vir Biotechnology, Inc.
Biotechnology
2022
Grant Agreement between the Company and the Bill & Melinda Gates Foundation, dated November 5, 2021
Vir Biotechnology, Inc.
Biotechnology
2022
Amended and Restated Letter Agreement between the Company and the Bill & Melinda Gates Foundation, dated January 12, 2022
Vir Biotechnology, Inc.
2022
Grant Agreement between the Company and the Bill & Melinda Gates Foundation, dated January 12, 2022
Vir Biotechnology, Inc.
Biotechnology
2022
Amended and Restated Employment Letter Agreement between the Company and Ann M. Hanly, dated May 4, 2021
Employment Agreements
Vir Biotechnology, Inc.
Biotechnology
CA
2021
Third Amendment to Exclusive License Agreement between the Company and The Rockefeller University, dated March 1, 2021
License Agreements
Vir Biotechnology, Inc.
Biotechnology
2021
Amendment 1 to Patent License Agreement dated as of March 25, 2020, between the Company and Xencor, Inc., dated February 23, 2021
License Agreements
Vir Biotechnology, Inc.
Biotechnology
NY
2021
Amendment 1 to Patent License Agreement dated as of August 15, 2019, between the Company and Xencor, Inc., dated February 23, 2021
License Agreements
Vir Biotechnology, Inc.
2021
Stock Purchase Agreement between the Company and Glaxo Group Limited, dated February 14, 2021
Stock Agreements
Vir Biotechnology, Inc.
2021
Preliminary Collaboration Agreement between the Company, GlaxoSmithKline Intellectual Property Development Limited and GlaxoSmithKline Biologicals SA, dated February 14, 2021
Collaboration Agreements
Vir Biotechnology, Inc.
Biotechnology
2021
Amendment No. 3 to the Grant Agreement between the Company and the Bill & Melinda Gates Foundation, dated May 22, 2020
Vir Biotechnology, Inc.
Biotechnology
2021
Form of Restricted Stock Unit Grant Notice and Unit Award Agreement under Vir Biotechnology, Inc. 2019 Equity Incentive Plan
Bonus & Incentive Agreements
Vir Biotechnology, Inc.
2021
Non-Employee Director Compensation Policy
Compensation Agreements
Vir Biotechnology, Inc.
2021
Letter Agreement between the Company and Alnylam Pharmaceuticals, Inc., dated December 23, 2020
Vir Biotechnology, Inc.
Biotechnology
2021
Amendment No. 1 to License Agreement between the Company and MedImmune, LLC, dated September 1, 2020
License Agreements
Vir Biotechnology, Inc.
2021
Amendment No. 4 to the Grant Agreement between the Company and the Bill & Melinda Gates Foundation, dated December 8, 2020
Vir Biotechnology, Inc.
Biotechnology
2021
Second Amendment to Exclusive License Agreement between the Company and The Rockefeller University, dated September 28, 2020
License Agreements
Vir Biotechnology, Inc.
2021
Promotion Letter Agreement between the Company and Steven Rice, dated July 30, 2020
Vir Biotechnology, Inc.
Biotechnology
2020
Employment Letter Agreement between the Company and Steven Rice, dated August 22, 2019
Employment Agreements
Vir Biotechnology, Inc.
Biotechnology
CA
2020
Amendment No. 3 to the Grant Agreement between the Company and the Bill & Melinda Gates Foundation, dated May 29, 2020
Vir Biotechnology, Inc.
2020
Binding Letter Agreement between the Company and Samsung Biologics Co., Ltd., dated April 9, 2020
Vir Biotechnology, Inc.
2020
Form of Underwriting Agreement
Underwriting Agreements
Vir Biotechnology, Inc.
2020
Amendment No. 3 to the Collaboration and License Agreement between the Company and Alnylam Pharmaceuticals, Inc., dated April 1, 2020
Collaboration Agreements
Vir Biotechnology, Inc.
2020
Preliminary Collaboration Agreement between the Company, GlaxoSmithKline Intellectual Property Development Limited and GlaxoSmithKline Biologicals SA, dated April 5, 2020
Collaboration Agreements
Vir Biotechnology, Inc.
Biotechnology
DE
2020
Definitive Collaboration Agreement between the Company and Glaxo Wellcome UK Limited and Beecham S.A., dated June 9, 2020
Collaboration Agreements
Vir Biotechnology, Inc.
Biotechnology
DE
2020
Stock Purchase Agreement between the Company and Glaxo Group Limited, dated April 5, 2020
Stock Agreements
Vir Biotechnology, Inc.
Biotechnology
DE
2020
Clinical Development and Manufacturing Agreement between the Company and Biogen Inc., dated May 22, 2020
Development Agreements
Vir Biotechnology, Inc.
Biotechnology
DE
2020
Development and Manufacturing Collaboration Agreement between the Company and Wuxi Biologics (Hong Kong) Limited, dated February 25, 2020
Collaboration Agreements
Vir Biotechnology, Inc.
Biotechnology
IL
2020
Letter of Intent between the Company and Wuxi Biologics (Hong Kong) Limited, dated June 15, 2020
Vir Biotechnology, Inc.
2020
First Amendment to Amended and Restated Employment Letter Agreement between the Company and Michael Kamarck, dated March 13, 2020
Employment Agreements
Vir Biotechnology, Inc.
2020
Amendment No. 1 to the Collaboration and License Agreement between the Company and Alnylam Pharmaceuticals, Inc., dated December 17, 2019
Collaboration Agreements
Vir Biotechnology, Inc.
2020
Amendment No. 2 to the Collaboration and License Agreement between the Company and Alnylam Pharmaceuticals, Inc., dated March 3, 2020
Collaboration Agreements
Vir Biotechnology, Inc.
Biotechnology
2020
Amendment No. 1 to the Common Stock Issuance Agreement between the Company and Alnylam Pharmaceuticals, Inc., dated December 17, 2019
Stock Agreements
Vir Biotechnology, Inc.
Biotechnology
2020
Amendment No. 1 to the Grant Agreement between the Company and the Bill & Melinda Gates Foundation, dated April 18, 2019
Vir Biotechnology, Inc.
2020
Amendment No. 2 to the Grant Agreement between the Company and the Bill & Melinda Gates Foundation, dated February 24, 2020
Vir Biotechnology, Inc.
Biotechnology
2020
Amendment No. 1 to the Grant Agreement between the Company and the Bill & Melinda Gates Foundation, dated April 22, 2019
Vir Biotechnology, Inc.
2020
Amendment No. 2 to the Grant Agreement between the Company and the Bill & Melinda Gates Foundation, dated October 28, 2019
Vir Biotechnology, Inc.
Biotechnology
2020
Description of Capital Stock
Stock Agreements
Vir Biotechnology, Inc.
Biotechnology
2020
Form of Underwriting Agreement
Underwriting Agreements
Vir Biotechnology, Inc.
2019
Form of Common Stock Certificate of the Registrant
Stock Agreements
Vir Biotechnology, Inc.
2019
Vir Biotechnology, Inc. 2019 Equity Incentive Plan
Bonus & Incentive Agreements
Vir Biotechnology, Inc.
Biotechnology
DE
2019
2019 Employee Stock Purchase Plan
Stock Agreements
Vir Biotechnology, Inc.
Biotechnology
2019
Non-Employee Director Compensation Policy
Compensation Agreements
Vir Biotechnology, Inc.
2019
Vir Biotechnology, Inc. 2016 Equity Incentive Plan, as amended
Bonus & Incentive Agreements
Vir Biotechnology, Inc.
2019
Collaboration and License Agreement between the Registrant and Alnylam Pharmaceuticals, Inc., dated October 16, 2017
Collaboration Agreements
Vir Biotechnology, Inc.
2019
Vir Biotechnology, Inc. Change in Control and Severance Benefit Plan
Change of Control Agreements
Vir Biotechnology, Inc.
2019
Amended and Restated Employment Letter Agreement between the Registrant and Herbert Virgin, dated September 3, 2019
Employment Agreements
Vir Biotechnology, Inc.
Biotechnology
CA
2019
Amended and Restated Employment Letter Agreement between the Registrant and Jay Parrish, dated August 27, 2019
Employment Agreements
Vir Biotechnology, Inc.
2019
Amended and Restated Employment Letter Agreement between the Registrant and Phil Pang, dated August 27, 2019
Employment Agreements
Vir Biotechnology, Inc.
2019
Amended and Restated Employment Letter Agreement between the Registrant and Michael Kamarck, dated August 28, 2019
Employment Agreements
Vir Biotechnology, Inc.
2019
Amended and Restated Employment Letter Agreement between the Registrant and Howard Horn, dated August 27, 2019
Employment Agreements
Vir Biotechnology, Inc.
Biotechnology
CA
2019
Amended and Restated Employment Letter Agreement between the Registrant and George Scangos, dated August 27, 2019
Employment Agreements
Vir Biotechnology, Inc.
Biotechnology
CA
2019
Non-Employee Director Compensation Policy
Compensation Agreements
Vir Biotechnology, Inc.
Biotechnology
2019
2019 Employee Stock Purchase Plan
Stock Agreements
Vir Biotechnology, Inc.
Biotechnology
2019
Forms of Incentive Stock Option Notice and Agreement, Non-Qualified Stock Option Notice and Agreement, Restricted Stock Agreement and Restricted Stock Purchase Agreement under the...
Bonus & Incentive Agreements
Vir Biotechnology, Inc.
2019
Common Stock Issuance Agreement between the Registrant and Alnylam Pharmaceuticals, Inc., dated October 16, 2017
Stock Agreements
Vir Biotechnology, Inc.
2019
Form of Restricted Stock Unit Grant Notice and Unit Award Agreement under Vir Biotechnology, Inc. 2019 Equity Incentive Plan
Bonus & Incentive Agreements
Vir Biotechnology, Inc.
Biotechnology
2019
Forms of Option Grant Notice and Option Agreement under Vir Biotechnology, Inc. 2019 Equity Incentive Plan
Bonus & Incentive Agreements
Vir Biotechnology, Inc.
Biotechnology
IL
2019
Vir Biotechnology, Inc. 2019 Equity Incentive Plan
Bonus & Incentive Agreements
Vir Biotechnology, Inc.
2019
Form of Indemnity Agreement by and between the Registrant and its directors and executive officers
Vir Biotechnology, Inc.
2019
Amended and Restated Warrant, issued to Takeda Ventures, Inc
Warrant Agreements
Vir Biotechnology, Inc.
Biotechnology
DE
2019
Amended and Restated Investors Rights Agreement, by and among the Registrant and certain of its stockholders, dated November 29, 2017
Investor Rights Agreements
Vir Biotechnology, Inc.
2019
Amendment 6 to Sub-License and Collaboration Agreement, dated September 7, 2018, between the Registrant (as successor in interest to Humabs BioMed SA) and MedImmune, LLC, dated...
Collaboration Agreements
Vir Biotechnology, Inc.
2019
Lease Agreement between the Registrant and ARE-SAN FRANCISCO NO. 43, LLC, dated March 30, 2017
Lease Agreements
Vir Biotechnology, Inc.
2019
First Amendment to Lease between the Registrant and ARE-SAN FRANCISCO NO. 43, LLC, dated April 10, 2019
Lease Agreements
Vir Biotechnology, Inc.
Biotechnology
2019
Patent License Agreement between the Registrant and Xencor, Inc., dated August 15, 2019
License Agreements
Vir Biotechnology, Inc.
2019
Amendment to Amended and Restated Exclusive License Agreement between the Registrant (as successor in interest to Humabs BioMed SA (f/k/a Humabs Holding GmbH)) and the Institute...
License Agreements
Vir Biotechnology, Inc.
2019
Amendment 4 to Sub-License and Collaboration Agreement, dated August 29, 2016, between the Registrant (as successor in interest to Humabs BioMed SA) and MedImmune, LLC, dated...
Collaboration Agreements
Vir Biotechnology, Inc.
Biotechnology
2019
Amendment 3 to Sub-License and Collaboration Agreement, dated December 31, 2015, between the Registrant (as successor in interest to Humabs BioMed SA) and MedImmune, LLC, dated...
Collaboration Agreements
Vir Biotechnology, Inc.
Biotechnology
2019
Amendment 2 to Sub-License and Collaboration Agreement, dated April 27, 2015, between the Registrant (as successor in interest to Humabs BioMed SA) and MedImmune, LLC, dated March...
Collaboration Agreements
Vir Biotechnology, Inc.
2019
Amendment 1 to Sub-License and Collaboration Agreement, dated April 19, 2013, between the Registrant (as successor in interest to Humabs BioMed SA) and MedImmune, LLC, dated March...
Collaboration Agreements
Vir Biotechnology, Inc.
2019
Collaboration, Option, and License Agreement between the Registrant and Brii Biosciences Limited (previously named BiiG Therapeutics Limited), dated May 23, 2018
Collaboration Agreements
Vir Biotechnology, Inc.
Biotechnology
NY
2019
Amendment to Exclusive License Agreement between the Registrant and The Rockefeller University, dated May 17, 2019
License Agreements
Vir Biotechnology, Inc.
2019
Exclusive License Agreement between the Registrant and The Rockefeller University, dated July 31, 2018
License Agreements
Vir Biotechnology, Inc.
2019
Amendment Agreement between the Registrant (as successor in interest to Humabs BioMed SA) and the Institute for Research in Biomedicine, dated January 29, 2018
Vir Biotechnology, Inc.
2019
Amendment to License Agreement between the Registrant (as successor in interest to Humabs BioMed SA) and the Institute for Research in Biomedicine, dated February 10, 2012
License Agreements
Vir Biotechnology, Inc.
Biotechnology
2019
Exclusive License Agreement between the Registrant (as successor in interest to Humabs BioMed SA) and the Institute for Research in Biomedicine, dated December 16, 2011
License Agreements
Vir Biotechnology, Inc.
2019
Amendment 5 to Sub-License and Collaboration Agreement, dated July 15, 2017, between the Registrant (as successor in interest to Humabs BioMed SA) and MedImmune, LLC, dated March...
Collaboration Agreements
Vir Biotechnology, Inc.
Biotechnology
2019
Amended and Restated Exclusive License Agreement between the Registrant (as successor in interest to Humabs BioMed SA (f/k/a Humabs Holding GmbH)) and the Institute for Research...
License Agreements
Vir Biotechnology, Inc.
2019
Grant Agreement between the Registrant and the Bill & Melinda Gates Foundation, dated March 16, 2018
Vir Biotechnology, Inc.
2019
Grant Agreement between the Registrant and the Bill & Melinda Gates Foundation, dated January 26, 2018
Vir Biotechnology, Inc.
Biotechnology
2019
Letter Agreement between the Registrant and the Bill & Melinda Gates Foundation, dated December 23, 2016
Vir Biotechnology, Inc.
Biotechnology
WA
2019
Securities Purchase Agreement between the Registrant, Humabs BioMed SA, the shareholders of Humabs set forth therein, the option-holders of Humabs set forth therein and Fortis...
Purchase Agreements
Vir Biotechnology, Inc.
2019
Agreement and Plan of Merger between the Registrant, Vir Merger Sub, Inc., Agenovir Corporation, and Dr. Stephen R. Quake, dated January 2, 2018
Merger Agreements
Vir Biotechnology, Inc.
2019
Letter Agreement between the Registrant and the stockholders of TomegaVax, Inc. set forth therein, dated September 12, 2016
Vir Biotechnology, Inc.
Biotechnology
2019
Second Revised and Restated Master License Agreement between the Registrant and Oregon Health & Science University, dated August 27, 2019
License Agreements
Vir Biotechnology, Inc.
Biotechnology
OR
2019
License Agreement between the Registrant and MedImmune, LLC, dated September 7, 2018
License Agreements
Vir Biotechnology, Inc.
2019
Letter Agreement between the Registrant and Alnylam Pharmaceuticals, Inc., dated November 13, 2018
Vir Biotechnology, Inc.
Biotechnology
2019